Inflexal^® V is based on Crucell’s virosome technology, produced in line with the annual WHO recommendations. It is the only adjuvanted Flu vaccine licensed for all age groups up from six months.

Inflexal^® V has a proven market experience with more than 34 million doses of vaccine reconfirming its safety profile. The tolerability of Inflexal^® V is excellent due to its biocompatibility and purity, resulting in smooth protection against influenza. Neither thiomersal nor formaldehyde is contained within the vaccine (free of aluminium and thiosermal). The manufacturing process of Inflexal^® V allows residual quantities of antibiotics, detergent and hen’s egg protein (represented by the ovalbumin content) to be minimal compared with other influenza vaccines.